Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
4 yr
Consecutive declineDecelerating
PeriodValue
2025-13.65%
2024-9.15%
20232.28%
202231.93%
2021121.81%
202030.94%
20190.00%